IMARC Group has recently released a new research study titled “IMARC Group has recently released a new research study titled “”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.

 

Market Overview

The United States biobanking market share reached USD 15.9 Billion in 2024 and is expected to grow to USD 34.0 Billion by 2033. The market is forecasted to expand at a CAGR of 7.91% during the period from 2025 to 2033. Biobanking serves as a critical resource for advancing medical knowledge and improving healthcare outcomes by providing reliable access to high-quality biological samples and associated data. The market’s growth is driven by its vital role in diagnostics, drug development, personalized medicine, and the digital transformation of health systems. 

Study Assumption Years

  • Base Year: 2024

  • Historical Year/Period: 2019-2024

  • Forecast Year/Period: 2025 to 2033

United States Biobanking Market Key Takeaways

  • Current Market Size: USD 15.9 Billion in 2024

  • CAGR: 7.91% (2025-2033)

  • Forecast Period: 2025 to 2033

  • Biobanking involves collection, storage, annotation, and distribution of biological samples for research.

  • It plays a key role in diagnostics, therapeutic developments, and personalized medicine.

  • The market is supported by stringent quality control improving reproducibility of scientific experiments.

  • Data from biobanking facilitates digital transformation of health systems.

  • Growth is driven by increasing demand for precision medicine and targeted therapies.

Sample Request Link: https://www.imarcgroup.com/united-states-biobanking-market/requestsample

United States Biobanking Market Growth Factors

The United States biobanking market growth is fueled primarily by its role in advancing medical knowledge and enhancing healthcare outcomes. In 2024, the market size was USD 15.9 Billion, expected to nearly double by 2033 reaching USD 34.0 Billion, exhibiting a CAGR of 7.91%. This significant growth is driven by the expanding use of biobanking as an invaluable resource in medical research, diagnostics, and drug discovery, enabling better understanding and treatment of various diseases.

Biobanking enables the systematic collection and storage of bodily fluids and tissue samples, providing researchers with access to high-quality biological materials essential for developing personalized medical approaches. The identification of effective biomarkers through biobanking is crucial for disease diagnosis and prognosis, supporting drug and biomarker development, clinical therapy, and clinical trial monitoring. These applications contribute fundamentally to the demand growth in this market.

Stringent quality control measures are employed in biobanking, leading to improved reproducibility of experiments which enhances scientific validity and reliability. Moreover, data generated from biological samples supports the ongoing digital transformation of health systems by enabling advanced data analytics and digital health research. The increasing demand for precision medicine and targeted therapies further stimulates market expansion, making the United States biobanking market poised for sustained growth through the forecast period.

To get more information on this market, Request Sample

United States Biobanking Market Segmentation

Breakup By Specimen Type:

  • Blood Products: Includes blood-derived samples essential for various diagnostic and research applications.

  • Solid Tissue: Biobanking of solid tissue samples for disease research and therapeutic development.

  • Cell Lines: Collections of cultured cells used extensively for medical and scientific research.

  • Nucleic Acid: Storage and distribution of DNA/RNA samples for genetic and molecular analysis.

  • Others

Breakup By Biobank Type:

  • Population-based Biobanks: Biobanks collecting samples from general populations for epidemiological studies.

  • Disease-oriented Biobanks: Focused collections oriented towards specific diseases to assist targeted research.

Breakup By Application:

  • Therapeutics: Use of biobanked samples for therapy development and medical treatment.

  • Research: Utilization in scientific studies aimed at understanding health and disease mechanisms.

Breakup By End User:

  • Academic Institutions: Universities and research institutes using biobanking for scientific investigations.

  • Pharma and Biotech Companies: Commercial entities leveraging biobanking for drug discovery and development.

Breakup By Region:

  • Northeast

  • Midwest

  • South

  • West

Each segment and sub-segment reflects comprehensive research and analysis as presented in the report.

Regional Insights

The report provides a comprehensive analysis of major regional markets including the Northeast, Midwest, South, and West. While no explicit dominant region or statistical market share is stated, the segmentation indicates widespread biobanking market presence across these key U.S. regions, suggesting a broad geographic distribution of market activities throughout the country.

Competitive Landscape

The market research report covers a comprehensive competitive landscape analysis including market structure, key player positioning, winning strategies, competitive dashboards, and company evaluation quadrants. Detailed profiles of all major companies have been provided.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=20668&flag=C

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

 

United States: +1-201971-6302